{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:08:58Z","timestamp":1791554938481,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ecl.2021.11.007","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T15:56:58Z","timestamp":1644335818000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men"],"prefix":"10.1016","volume":"51","author":[{"suffix":"Jr.","given":"Harrison G.","family":"Pope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2021.11.007_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"10.1016\/j.ecl.2021.11.007_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1592\/phco.31.8.757","article-title":"The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training","volume":"31","author":"Ip","year":"2011","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.ecl.2021.11.007_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000505978","article-title":"Anabolic-androgenic steroid use and body image in men: a growing concern for clinicians","volume":"89","author":"Kanayama","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","article-title":"Anabolic androgenic steroids: a survey of 500 users","volume":"38","author":"Parkinson","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"10.1016\/j.ecl.2021.11.007_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3928\/00485713-20121003-05","article-title":"Misconceptions about anabolic-androgenic steroid abuse","volume":"42","author":"Kanayama","year":"2012","journal-title":"Psychiatr Ann"},{"key":"10.1016\/j.ecl.2021.11.007_bib6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1521-0391.2013.00311.x","article-title":"Performance-enhancing drugs on the web: A growing public-health issue","volume":"22","author":"Brennan","year":"2013","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0838.2005.00442.x","article-title":"Research of stimulants and anabolic steroids in dietary supplements","volume":"16","author":"Baume","year":"2006","journal-title":"Scand J Med Sci Sports"},{"issue":"7","key":"10.1016\/j.ecl.2021.11.007_bib8","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jms.1452","article-title":"Nutritional supplements cross-contaminated and faked with doping substances","volume":"43","author":"Geyer","year":"2008","journal-title":"J\u00a0Mass Spectrom"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib9","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s10620-008-0457-x","article-title":"Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review","volume":"54","author":"Nasr","year":"2009","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.ecl.2021.11.007_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/andr.307","article-title":"Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem","volume":"3","author":"Rahnema","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.ecl.2021.11.007_bib11","series-title":"The Adonis complex: the secret crisis of male body obsession","author":"Pope","year":"2000"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1098-108X(199907)26:1<65::AID-EAT8>3.0.CO;2-D","article-title":"Evolving ideals of male body image as seen through action toys","volume":"26","author":"Pope","year":"1999","journal-title":"Int J Eat Disord"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000056252","article-title":"The growing commercial value of the male body: a longitudinal survey of advertising in women's magazines","volume":"70","author":"Pope","year":"2001","journal-title":"Psychother Psychosom"},{"issue":"2","key":"10.1016\/j.ecl.2021.11.007_bib14","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1542\/peds.2004-2022","article-title":"Exposure to the mass media, body shape concerns, and use of supplements to improve weight and shape among male and female adolescents","volume":"116","author":"Field","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2010.09.018","article-title":"The diagnostic dilemma of pathological appearance and performance enhancing drug use","volume":"114","author":"Hildebrandt","year":"2011","journal-title":"Drug and alcohol dependence"},{"issue":"3","key":"10.1016\/j.ecl.2021.11.007_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/eat.10019","article-title":"The media's representation of the ideal male body: a cause for muscle dysmorphia?","volume":"31","author":"Leit","year":"2002","journal-title":"Int J Eat Disord"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1557988306309408","article-title":"A\u00a0review of body image influences on men's fitness goals and supplement use","volume":"1","author":"McCreary","year":"2007","journal-title":"Am J Mens Health"},{"issue":"6","key":"10.1016\/j.ecl.2021.11.007_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0033-3182(97)71400-2","article-title":"Muscle dysmorphia. An underrecognized form of body dysmorphic disorder","volume":"38","author":"Pope","year":"1997","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.ecl.2021.11.007_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.comppsych.2005.06.001","article-title":"Presence of muscle dysmorphia symptomology among male weightlifters","volume":"47","author":"Hildebrandt","year":"2006","journal-title":"Compr Psychiatry"},{"issue":"3","key":"10.1016\/j.ecl.2021.11.007_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/10640260902848477","article-title":"The relationship between anabolic androgenic steroids and muscle dysmorphia: a review","volume":"17","author":"Rohman","year":"2009","journal-title":"Eat Disord"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib21","first-page":"31","article-title":"Anabolic-androgenic steroid dependence","volume":"50","author":"Brower","year":"1989","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ecl.2021.11.007_bib22","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","article-title":"Anabolic-androgenic steroid dependence: an emerging disorder","volume":"104","author":"Kanayama","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.ecl.2021.11.007_bib23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biopsych.2011.06.024","article-title":"Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: A cross-sectional cohort study","volume":"71","author":"Pope","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ecl.2021.11.007_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","article-title":"The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates","volume":"23","author":"Pope","year":"2014","journal-title":"Am J Addict"},{"issue":"8","key":"10.1016\/j.ecl.2021.11.007_bib25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1176\/ajp.146.8.1075a","article-title":"Anabolic androgenic steroids and suicide","volume":"146","author":"Brower","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10401239909147074","article-title":"Anabolic androgenic steroids and suicide","volume":"11","author":"Thiblin","year":"1999","journal-title":"Ann Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.ecl.2021.11.007_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archpsyc.61.10.997","article-title":"The effects of pharmacologically induced hypogonadism on mood in healthy men","volume":"61","author":"Schmidt","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.ecl.2021.11.007_bib28","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.psyneuen.2003.11.002","article-title":"One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men","volume":"29","author":"Almeida","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib29","first-page":"130","article-title":"The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series","volume":"53","author":"Malone","year":"1992","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/add.12850","article-title":"Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an underrecognized problem","volume":"110","author":"Kanayama","year":"2015","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes","volume":"51","author":"Pope","year":"1994","journal-title":"Arch Gen Psychiatry"},{"issue":"22","key":"10.1016\/j.ecl.2021.11.007_bib32","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1001\/jama.1989.03430220089036","article-title":"Hooked on hormones? An anabolic steroid addiction hypothesis","volume":"262","author":"Kashkin","year":"1989","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib33","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.fertnstert.2011.04.029","article-title":"Persistent primary hypogonadism associated with anabolic steroid abuse","volume":"96","author":"Boregowda","year":"2011","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.ecl.2021.11.007_bib34","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/humrep\/12.8.1706","article-title":"Conservative management of azoospermia following steroid abuse","volume":"12","author":"Gazvani","year":"1997","journal-title":"Hum Reprod"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/036354659001800417","article-title":"Anabolic steroid-induced hypogonadotropic hypogonadism","volume":"18","author":"Jarow","year":"1990","journal-title":"Am J Sports Med"},{"issue":"7049","key":"10.1016\/j.ecl.2021.11.007_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bmj.313.7049.100","article-title":"Anabolic steroid abuse by body builders and male subfertility","volume":"313","author":"Lloyd","year":"1996","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2021.11.007_bib37","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0015-0282(03)00365-0","article-title":"Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin","volume":"79","author":"Menon","year":"2003","journal-title":"Fertil Steril"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib38","first-page":"1628","article-title":"The reversibility of anabolic steroid-induced azoospermia","volume":"153","author":"Turek","year":"1995","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.ecl.2021.11.007_bib39","doi-asserted-by":"crossref","first-page":"2331.e1-3","DOI":"10.1016\/j.fertnstert.2010.03.042","article-title":"Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism","volume":"94","author":"Pirola","year":"2010","journal-title":"Fertil Steril"},{"issue":"6","key":"10.1016\/j.ecl.2021.11.007_bib40","first-page":"2200","article-title":"Anabolic steroid induced hypogonadism in young men","volume":"190","author":"Coward","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"8","key":"10.1016\/j.ecl.2021.11.007_bib41","doi-asserted-by":"crossref","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","article-title":"Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study","volume":"11","author":"Rasmussen","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.14341\/probl12223","article-title":"[Peculiarity of recovery of the hypothalamic-pituitary-gonadal (hpg) axis, in men after using androgenic anabolic steroids]","volume":"66","author":"Lykhonosov","year":"2020","journal-title":"Probl Endokrinol (Mosk)"},{"issue":"11","key":"10.1016\/j.ecl.2021.11.007_bib43","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1111\/j.1464-410X.2011.10131.x","article-title":"Anabolic steroids and male infertility: a comprehensive review","volume":"108","author":"de Souza","year":"2011","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib44","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertil Steril"},{"issue":"9","key":"10.1016\/j.ecl.2021.11.007_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1360-0443.2004.00781.x","article-title":"Anabolic steroid users' attitudes towards physicians","volume":"99","author":"Pope","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.ecl.2021.11.007_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1677\/joe.0.1700055","article-title":"Drugs in sport -- the role of the physician","volume":"170","author":"Dawson","year":"2001","journal-title":"J\u00a0Endocrinol"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00007256-200232050-00001","article-title":"Anabolic steroids: a review for the clinician","volume":"32","author":"Kutscher","year":"2002","journal-title":"Sports Med"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00042752-199510000-00003","article-title":"Fat-free mass index in users and nonusers of anabolic-androgenic steroids","volume":"5","author":"Kouri","year":"1995","journal-title":"Clin J Sport Med"},{"issue":"3","key":"10.1016\/j.ecl.2021.11.007_bib49","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2013-1058","article-title":"Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement","volume":"35","author":"Pope","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ecl.2021.11.007_bib50","first-page":"28","article-title":"Can you tell if your patient is using anabolic steroids?","volume":"1","author":"Pope","year":"2005","journal-title":"Curr Psychiatry Prim Care"},{"key":"10.1016\/j.ecl.2021.11.007_bib51","series-title":"The American Psychiatric Publishing Textbook of Substance Abuse Treatment","first-page":"263","article-title":"Treatment of anabolic-androgenic steroid related disorders","author":"Pope","year":"2015"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0015-0282(02)04550-8","article-title":"Use of clomiphene citrate to reverse premature andropause secondary to steroid abuse","volume":"79","author":"Tan","year":"2003","journal-title":"Fertil Steril"},{"issue":"4","key":"10.1016\/j.ecl.2021.11.007_bib53","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bju.14390","article-title":"Combination therapy with clomiphene citrate and anastrozole is a safe and effective alternative for hypoandrogenic subfertile men","volume":"122","author":"Alder","year":"2018","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ecl.2021.11.007_bib54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/sj.ijir.3900981","article-title":"Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?","volume":"15","author":"Guay","year":"2003","journal-title":"Int J Impot Res"},{"issue":"6","key":"10.1016\/j.ecl.2021.11.007_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.mehy.2008.12.042","article-title":"Anabolic steroid-induced hypogonadism--towards a unified hypothesis of anabolic steroid action","volume":"72","author":"Tan","year":"2009","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.ecl.2021.11.007_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5534\/wjmh.190002","article-title":"Management of Anabolic Steroid-Induced Infertility: Novel Strategies for Fertility Maintenance and Recovery","volume":"38","author":"Tatem","year":"2020","journal-title":"World J Mens Health"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib57","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/cen.12641","article-title":"Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and\/or mitigation of adverse effects","volume":"82","author":"Karavolos","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ecl.2021.11.007_bib58","series-title":"Anabolics","author":"Llewellyn","year":"2017"},{"issue":"1","key":"10.1016\/j.ecl.2021.11.007_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00042752-199501000-00005","article-title":"Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users","volume":"5","author":"Malone","year":"1995","journal-title":"Clin J Sport Med"},{"issue":"5","key":"10.1016\/j.ecl.2021.11.007_bib60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/070674379403900525","article-title":"Anabolic steroid withdrawal depression: a case report","volume":"39","author":"Allnutt","year":"1994","journal-title":"Can J Psychiatry"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921001079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852921001079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:47:32Z","timestamp":1760176052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852921001079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0889852921001079"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2021.11.007","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2021.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}